Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Once-daily versus twice-daily levobunolol (0.5%) therapy. A crossover study.
Derick RJ, Robin AL, Tielsch J, Wexler JL, Kelley EP, Stoecker JF, Novack GD, Coleman AL. Derick RJ, et al. Among authors: novack gd. Ophthalmology. 1992 Mar;99(3):424-9. doi: 10.1016/s0161-6420(92)31957-8. Ophthalmology. 1992. PMID: 1565455 Free article. Clinical Trial.
Efficacy and safety of once-daily levobunolol for glaucoma therapy.
Rakofsky SI, Lazar M, Almog Y, LeBlanc RP, Mann C, Orr A, Lee PF, Friedland BR, Novack GD, Kelley EP, et al. Rakofsky SI, et al. Among authors: novack gd. Can J Ophthalmol. 1989 Feb;24(1):2-6. Can J Ophthalmol. 1989. PMID: 2653592 Clinical Trial.
Glaucoma treatment with once-daily levobunolol.
David R, Foerster RJ, Ober M, Cohen JS, Kelley EP, Lue JC, Novack GD. David R, et al. Among authors: novack gd. Am J Ophthalmol. 1987 Oct 15;104(4):443-4. doi: 10.1016/0002-9394(87)90255-8. Am J Ophthalmol. 1987. PMID: 3310644 No abstract available.
Glaucoma treatment with once-daily levobunolol.
Wandel T, Charap AD, Lewis RA, Partamian L, Cobb S, Lue JC, Novack GD, Gaster R, Smith J, Duzman E. Wandel T, et al. Among authors: novack gd. Am J Ophthalmol. 1986 Mar 15;101(3):298-304. doi: 10.1016/0002-9394(86)90823-8. Am J Ophthalmol. 1986. PMID: 3513594 Clinical Trial.
337 results